|
|
negative regulation of androgen receptor activity
|
GO:2000824 |
2 |
0.990
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.965
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.935
|
Human |
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.916
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.863
|
Mouse |
|
|
intermediate filament based process
|
GO:0045103 |
17 |
0.839
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.814
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.802
|
Human |
|
|
smooth muscle cell differentiation
|
GO:0051145 |
8 |
0.791
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
3 |
0.760
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.736
|
Human |
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.661
|
Human |
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
17 |
0.604
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.593
|
|
|
|
negative regulation of protein complex assembly
|
GO:0031333 |
43 |
0.558
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.546
|
Human |
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.536
|
Human |
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.512
|
Human |
|
|
vascular smooth muscle cell differentiation
|
GO:0035886 |
3 |
0.481
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.469
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.423
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.419
|
Human |
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.413
|
|
|
|
regulation of androgen receptor activity
|
GO:2000823 |
3 |
0.412
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.410
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
20 |
0.392
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.391
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.376
|
Human |
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.373
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.361
|
Human |
|
|
tube development
|
GO:0035295 |
125 |
0.344
|
Mouse |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.342
|
|
|
|
kidney epithelium development
|
GO:0072073 |
25 |
0.341
|
Mouse |
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.339
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.325
|
Human |
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
27 |
0.323
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.319
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
14 |
0.319
|
Mouse |
|
|
response to host defenses
|
GO:0052200 |
2 |
0.307
|
Human |
|
|
ventricular septum morphogenesis
|
GO:0060412 |
3 |
0.306
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
23 |
0.303
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.281
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.275
|
Human |
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.270
|
Human |
|
|
intermediate filament organization
|
GO:0045109 |
10 |
0.270
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.266
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.263
|
Human |
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.251
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.248
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
35 |
0.242
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.231
|
Mouse |
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.230
|
Human |
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.224
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.219
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.214
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.213
|
Human |
|
|
chromatin organization
|
GO:0006325 |
351 |
0.212
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.207
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.206
|
|
|
|
renal tubule development
|
GO:0061326 |
19 |
0.204
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.202
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.199
|
Mouse |
|
|
chaperone mediated protein folding
|
GO:0061077 |
13 |
0.197
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.195
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.193
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.193
|
Human |
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.188
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.185
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.179
|
|
|
|
microtubule polymerization or depolymerization
|
GO:0031109 |
37 |
0.179
|
|
|
|
regulation of alkaline phosphatase activity
|
GO:0010692 |
2 |
0.178
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.174
|
|
|
|
evasion or tolerance of host defenses by virus
|
GO:0019049 |
2 |
0.170
|
Human |
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.168
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.167
|
|
|
|
endocardial cushion development
|
GO:0003197 |
3 |
0.165
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.162
|
Human |
|
|
heart valve formation
|
GO:0003188 |
2 |
0.162
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
60 |
0.160
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.159
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.159
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.158
|
Mouse |
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.155
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.152
|
|
|
|
cell fate commitment
|
GO:0045165 |
27 |
0.148
|
|
|
|
negative regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033144 |
18 |
0.148
|
|
|
|
osteoblast development
|
GO:0002076 |
2 |
0.147
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.144
|
Human Zebrafish |
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.142
|
Zebrafish |
|
|
regulation of microtubule polymerization or depolymerization
|
GO:0031110 |
27 |
0.141
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.140
|
Human |
|
|
regulation of transcription regulatory region dna binding
|
GO:2000677 |
15 |
0.134
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.134
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.132
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.131
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.129
|
Human |
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.127
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.127
|
|
|
|
negative regulation of receptor activity
|
GO:2000272 |
15 |
0.127
|
|
|
|
hard palate development
|
GO:0060022 |
1 |
0.123
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.123
|
Human |
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.122
|
Human |
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.122
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.122
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.119
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.119
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
14 |
0.118
|
Mouse |
|
|
muscle organ morphogenesis
|
GO:0048644 |
19 |
0.117
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.116
|
Human |
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.116
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.110
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.107
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.107
|
Human |
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.103
|
Zebrafish |
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.103
|
Human |
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.102
|
Human |
|
|
protein folding
|
GO:0006457 |
38 |
0.101
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
53 |
0.100
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.100
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.099
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.099
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.099
|
|
|
|
regulation of microtubule polymerization
|
GO:0031113 |
12 |
0.099
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.098
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.098
|
Human |
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.097
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.097
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.097
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.095
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.094
|
Zebrafish |
|
|
system process
|
GO:0003008 |
349 |
0.094
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.094
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.094
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.090
|
Human |
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.089
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.089
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.089
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.088
|
|
|
|
negative regulation of dna binding
|
GO:0043392 |
18 |
0.087
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.087
|
|
|
|
common partner smad protein phosphorylation
|
GO:0007182 |
3 |
0.087
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.086
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
14 |
0.084
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.084
|
Human |
|
|
biological adhesion
|
GO:0022610 |
331 |
0.084
|
|
|
|
nephron tubule development
|
GO:0072080 |
17 |
0.084
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
3 |
0.084
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.083
|
Human |
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.083
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.082
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.081
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.081
|
|
|
|
evasion or tolerance of host defenses
|
GO:0044415 |
2 |
0.081
|
Human |
|
|
positive regulation of protein polymerization
|
GO:0032273 |
45 |
0.079
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.079
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.078
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
4 |
0.077
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.077
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.076
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.076
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.075
|
Human |
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.075
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.075
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.074
|
|
|
|
s shaped body morphogenesis
|
GO:0072050 |
4 |
0.074
|
|
|
|
mitochondrion morphogenesis
|
GO:0070584 |
8 |
0.074
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.074
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.073
|
|
|
|
vacuole organization
|
GO:0007033 |
44 |
0.073
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.072
|
Mouse |
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.071
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.071
|
Human |
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
61 |
0.071
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.071
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.070
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.070
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.069
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.068
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.068
|
Human |
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.067
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.067
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.067
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.067
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.066
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.066
|
Human |
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.066
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
50 |
0.065
|
Human |
|
|
somitogenesis
|
GO:0001756 |
2 |
0.065
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.065
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.065
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.064
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.064
|
Human Mouse |
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.063
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.063
|
Human |
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.063
|
Human |
|
|
growth
|
GO:0040007 |
202 |
0.062
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.062
|
|
|
|
ureteric bud development
|
GO:0001657 |
13 |
0.062
|
Mouse |
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.062
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.061
|
Human |
|
|
zygotic specification of dorsal ventral axis
|
GO:0007352 |
2 |
0.061
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.060
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.058
|
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
23 |
0.058
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.057
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.056
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
10 |
0.056
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
2 |
0.056
|
|
|
|
multivesicular body sorting pathway
|
GO:0071985 |
4 |
0.054
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
14 |
0.053
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.053
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
19 |
0.053
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.053
|
Human |
|
|
immune response
|
GO:0006955 |
307 |
0.053
|
Human |
|
|
cardiac septum morphogenesis
|
GO:0060411 |
9 |
0.053
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.053
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.053
|
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.053
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
24 |
0.052
|
Human |
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.052
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.052
|
Human |
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
19 |
0.052
|
|
|
|
golgi organization
|
GO:0007030 |
38 |
0.052
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
3 |
0.052
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.051
|
Human |
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.051
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.051
|
Human |
|
|
tube closure
|
GO:0060606 |
3 |
0.051
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.051
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.051
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.051
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.050
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.050
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.050
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.050
|
Mouse |
|
|
urogenital system development
|
GO:0001655 |
65 |
0.050
|
Mouse |
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.050
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.049
|
Human |
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.048
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.048
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.048
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.047
|
|
|
|
renal vesicle development
|
GO:0072087 |
4 |
0.047
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.047
|
Human |
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.047
|
|
|
|
cellular response to histamine
|
GO:0071420 |
3 |
0.047
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.046
|
|
|
|
hair cycle
|
GO:0042633 |
28 |
0.046
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.046
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.046
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.046
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.046
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
107 |
0.046
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.046
|
Human |
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.045
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.045
|
Human |
|
|
angiogenesis
|
GO:0001525 |
147 |
0.045
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.045
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.044
|
|
|
|
response to defenses of other organism involved in symbiotic interaction
|
GO:0052173 |
2 |
0.044
|
Human |
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
21 |
0.044
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.044
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
2 |
0.044
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
47 |
0.044
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.043
|
|
|
|
ventricular septum development
|
GO:0003281 |
5 |
0.043
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.043
|
Human |
|
|
protein maturation
|
GO:0051604 |
233 |
0.043
|
Human |
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.043
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.043
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.043
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.042
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.042
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.041
|
Human Mouse |
|
|
positive regulation of axon extension
|
GO:0045773 |
4 |
0.041
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.041
|
Human |
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.041
|
Human |
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.041
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.040
|
Human |
|
|
lysosomal transport
|
GO:0007041 |
33 |
0.040
|
|
|
|
protein complex disassembly
|
GO:0043241 |
52 |
0.040
|
|
|
|
post golgi vesicle mediated transport
|
GO:0006892 |
36 |
0.040
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.040
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
56 |
0.040
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.040
|
|
|
|
convergent extension involved in gastrulation
|
GO:0060027 |
1 |
0.040
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
3 |
0.039
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
34 |
0.039
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.039
|
Human |
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.039
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.039
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.039
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.039
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.039
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.038
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.038
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.038
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.038
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.038
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.037
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.037
|
Human |
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.037
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.037
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.037
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.037
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.037
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.036
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.036
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.036
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.036
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
1 |
0.035
|
|
|
|
negative regulation of pathway restricted smad protein phosphorylation
|
GO:0060394 |
11 |
0.035
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.035
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.035
|
Human |
|
|
cell projection organization
|
GO:0030030 |
252 |
0.035
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.034
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
29 |
0.034
|
|
|
|
single organism carbohydrate catabolic process
|
GO:0044724 |
33 |
0.034
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.034
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.034
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.034
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.034
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.034
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.034
|
|
|
|
regulation of dna templated transcription initiation
|
GO:2000142 |
9 |
0.033
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.033
|
Human |
|
|
response to lipid
|
GO:0033993 |
206 |
0.033
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.033
|
Mouse |
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.033
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.033
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.033
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.033
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.032
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
37 |
0.032
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.032
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.032
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.032
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.032
|
|
|
|
regulation of blood volume by renal aldosterone
|
GO:0002017 |
1 |
0.032
|
|
|
|
neuronal stem cell division
|
GO:0036445 |
1 |
0.032
|
|
|
|
endosome to lysosome transport
|
GO:0008333 |
21 |
0.032
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.031
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.031
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.031
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
41 |
0.031
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.031
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.031
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.031
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.031
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.030
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.030
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.030
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.030
|
|
|
|
mesonephros development
|
GO:0001823 |
17 |
0.030
|
Mouse |
|
|
aldosterone biosynthetic process
|
GO:0032342 |
9 |
0.030
|
|
|
|
proximal tubule development
|
GO:0072014 |
1 |
0.030
|
|
|
|
regulation of pathway restricted smad protein phosphorylation
|
GO:0060393 |
34 |
0.030
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.030
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.030
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
61 |
0.030
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.029
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
50 |
0.029
|
|
|
|
lateral mesoderm development
|
GO:0048368 |
1 |
0.029
|
|
|
|
organelle localization
|
GO:0051640 |
84 |
0.029
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.029
|
|
|
|
endoderm development
|
GO:0007492 |
33 |
0.029
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
14 |
0.029
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.029
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
1 |
0.029
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.029
|
Human |
|
|
nephron epithelium development
|
GO:0072009 |
23 |
0.028
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.028
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.028
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.028
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
8 |
0.028
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.028
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.028
|
|
|
|
skeletal muscle tissue development
|
GO:0007519 |
24 |
0.028
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.028
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.028
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
3 |
0.028
|
|
|
|
somatic stem cell division
|
GO:0048103 |
1 |
0.028
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
19 |
0.028
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.028
|
Human |
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.027
|
Human |
|
|
microtubule polymerization
|
GO:0046785 |
18 |
0.027
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.027
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.027
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.027
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.027
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.027
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.027
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
83 |
0.027
|
|
|
|
negative regulation of microtubule polymerization or depolymerization
|
GO:0031111 |
17 |
0.027
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.027
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.027
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
46 |
0.027
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.027
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
8 |
0.026
|
|
|
|
aorta morphogenesis
|
GO:0035909 |
1 |
0.026
|
|
|
|
muscle cell fate commitment
|
GO:0042693 |
4 |
0.026
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.026
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.026
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
3 |
0.026
|
|
|
|
fat cell differentiation
|
GO:0045444 |
32 |
0.026
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.026
|
Human |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.026
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.026
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.026
|
|
|
|
protein modification by small protein removal
|
GO:0070646 |
92 |
0.026
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.026
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.025
|
Human |
|
|
digestive tract development
|
GO:0048565 |
75 |
0.025
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
10 |
0.025
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.025
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.025
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
6 |
0.025
|
|
|
|
aorta development
|
GO:0035904 |
2 |
0.025
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.025
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.025
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.025
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.025
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.024
|
Human |
|
|
cerebral cortex cell migration
|
GO:0021795 |
3 |
0.024
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.024
|
|
|
|
dendrite development
|
GO:0016358 |
24 |
0.024
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.024
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.024
|
Human |
|
|
metencephalon development
|
GO:0022037 |
2 |
0.024
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.024
|
Human |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.024
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
1 |
0.024
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.024
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.024
|
|
|
|
vacuolar transport
|
GO:0007034 |
34 |
0.024
|
|
|
|
midgut development
|
GO:0007494 |
1 |
0.024
|
|
|
|
regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060260 |
8 |
0.024
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
7 |
0.023
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.023
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.023
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
45 |
0.023
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.023
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.023
|
|
|
|
cellular response to ammonium ion
|
GO:0071242 |
4 |
0.023
|
|
|
|
vascular smooth muscle cell development
|
GO:0097084 |
1 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.023
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.023
|
Human |
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.022
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.022
|
Human |
|
|
response to potassium ion
|
GO:0035864 |
5 |
0.022
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.022
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.022
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.022
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.022
|
Human |
|
|
muscle system process
|
GO:0003012 |
81 |
0.022
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.022
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.022
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.022
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.022
|
Human |
|
|
negative regulation of multicellular organismal metabolic process
|
GO:0044252 |
3 |
0.022
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.022
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.022
|
Human |
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.021
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.021
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.021
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
10 |
0.021
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.021
|
Human |
|
|
embryo development
|
GO:0009790 |
123 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.021
|
Human |
|
|
catenin import into nucleus
|
GO:0035411 |
18 |
0.021
|
Human |
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.021
|
|
|
|
decidualization
|
GO:0046697 |
4 |
0.021
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.021
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
26 |
0.021
|
|
|
|
microtubule based movement
|
GO:0007018 |
32 |
0.021
|
|